STAT

OCTOBER 13, 2024

SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions, according to a person familiar with the situation and employee posts on social media. It is the latest in a series of retrenchments by high-profile gene-editing companies. A spokesperson for SalioGen declined to comment.

138

138

Drug Topics

OCTOBER 13, 2024

In case you missed it, this week we had stories about medication-related disaster preparedness, COVID-19 and cardiovascular risks, legal battles over inflated insulin prices, and more.

98

98

pharmaphorum

OCTOBER 13, 2024

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year.Marstacimab will be launched as Hympavzi to treat haemophilia A without factor VIII inhibitors and haemophilia B without factor IX inhibitors in patients aged 12 and older and is the first drug in the anti-TFPI class to be approved in the US.

FDA 71

FDA 71

The FDA Law Blog

OCTOBER 13, 2024

By Mark A. Tobolowsky — The Rare Pediatric Disease Priority Review Voucher program has had a bit of a tumultuous history in its 12 short years of existence. Designed to incentivize the development of drugs for pediatric rare diseases where such development may not otherwise have occurred, vouchers may be granted for drugs for serious or life-threatening rare diseases where the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years.

Documentation 59

Documentation FDA 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The Honest Apothecary

OCTOBER 13, 2024

Readers of The Honest Apothecary Re-Imagined are coming to learn that this blog has now become the home for short articles and thoughts on a wide variety of topics, well beyond the walls of the pharmacy. I still love medicine. But I needed a home for all the things I care deeply about. In that […] The post A Story in Five Colors – and simplify, simplify!

52

52

DiversifyRx

OCTOBER 13, 2024

Join the 75 Hard for Pharmacy Owners program to transform yourself and your pharmacy in Q4. You might think the only way to make massive changes in your pharmacy is to complete massive projects and changes. However, as an independent pharmacy owner, I’ve found that it’s not the massive changes but the small, consistent actions that can make the biggest difference.

Independent Pharmacies 52

Independent Pharmacies Compounding Immunization 52

Mission-Driven Marketing Blog

OCTOBER 13, 2024

Imagine your nonprofit’s donor database is suddenly lost, sensitive information exposed, website taken down, all because of a single click or missed update. For nonprofits, cybersecurity isn’t just about protecting data; it’s about safeguarding the trust your supporters place in you and ensuring the you can continue your mission.

52

52